NBY
Stablecoin Development Corp
Key Financials
Operating Income
$-8439000
↓ 44.5%
Revenue
$18.2M
↑ 53.2%
Gross Profit
$6.5M
↓ 17.9%
Net Income
$-22141000
↓ 206.5%
EPS (Diluted)
$-0.31
↑ 35.4%
Total Liabilities
$31.9M
↑ 797.0%
Total Assets
$9.0M
↑ 163.9%
Cash & Equivalents
$8.0M
↑ 1750.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/20/2026 | View on SEC |
| SCHEDULE 13D/A | 5/19/2026 | View on SEC |
| SCHEDULE 13D/A | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 4/A | 4/30/2026 | View on SEC |
| 4/A | 4/30/2026 | View on SEC |
| 4/A | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NBY |
| Company Name | Stablecoin Development Corp |
| CIK | 1389545 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (510) 899-8800 |